NCT06985875

Clinical Trial for the Evaluation of Safety and Efficacy of Drop 0.4%

Clinical Trial for the Evaluation of the Safety and Efficacy of a Moisturizing Solution With Hyaluronic Acid Drop 0.4%

• Status: Not Yet Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 79 (estimated)
• Sponsor: Avizor SA · Industry
• Sex: All
• Age: 18 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

The aim of the trial is to compare the safety and efficacy of the moisturizing solution DROP 0.4% with the moisturizing solution AVIZOR EYE DROPS 0.2% PRESERVED in relieving the symptoms of dry eye over one month of use.

Conditions

• Eye Dryness

Interventions

Type	Name	Description
DEVICE	Multidose mosturizing solution DROP 0.4%	Ophthalmic mosturizing solution to be administered 1-4 times per day in both eyes
DEVICE	Multidose mosturizing solution Avizor Eye Drops 0.2% Preserved	Ophthalmic mosturizing solution to be administered 1-4 times per day in both eyes

Timeline

• Start date: 2025-07-01
• Primary completion: 2025-12-31
• Completion: 2025-12-31
• First posted: 2025-05-22
• Last updated: 2025-07-09